Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040320667> ?p ?o ?g. }
- W2040320667 endingPage "349" @default.
- W2040320667 startingPage "344" @default.
- W2040320667 abstract "To investigate the potential effect of gliclazide on serum ICAM-1 (intercellular adhesion molecule-1) and VCAM-1 (vascular cell adhesion molecule-1) levels in poorly controlled type 2 diabetic patients.The study included 104 patients, randomly divided into two groups. Group A comprised 53 patients (26 men) treated with gliclazide with a mean age of 67.5+/-9.9 years, a mean diabetes duration of 13.4+/-5.4 years and a mean HbA1c of 8.6+/-1.1%. Group B comprised 51 patients (25 men) treated with glibenclamide with a mean age of 66.4+/-10.9 years, a mean diabetes duration of 13.2+/-6.1 years and a mean HbA1c of 8.4+/-1.3%. A third group of 30 healthy controls (15 men) with a mean age of 63.3+/-10.4 years was also included. Serum levels of ICAM-1 and VCAM-1 were measured at the beginning of the study and after six months of treatment.Pretreatment serum ICAM-1 and VCAM-1 levels did not differ between groups A and B, while they were significantly higher (P=0.0001) than in healthy controls. No significant difference in HbA1c, body mass index, blood pressure control and lipid profile between the two groups was observed after the sixth month of treatment. In group A, serum ICAM-1 levels after six months of treatment were significantly reduced from 623.12+/-61.17 ng/ml to 370.14+/-49.92 ng/ml (P=0,01), while no reduction was found in VCAM-1 levels. In group B, no reduction was found in serum ICAM-1 and VCAM-1 levels after the end of the study.Our results suggest that gliclazide treatment reduces serum ICAM-1 levels in poorly controlled type 2 diabetic patients. This reduction is independent of the hypoglycaemic action of gliclazide." @default.
- W2040320667 created "2016-06-24" @default.
- W2040320667 creator A5005046202 @default.
- W2040320667 creator A5007052598 @default.
- W2040320667 creator A5007500703 @default.
- W2040320667 creator A5008628863 @default.
- W2040320667 creator A5012710468 @default.
- W2040320667 creator A5013875458 @default.
- W2040320667 creator A5036267969 @default.
- W2040320667 creator A5058869854 @default.
- W2040320667 creator A5059338767 @default.
- W2040320667 creator A5082690870 @default.
- W2040320667 creator A5091649746 @default.
- W2040320667 date "2006-09-01" @default.
- W2040320667 modified "2023-10-14" @default.
- W2040320667 title "Gliclazide treatment lowers serum ICAM-1 levels in poorly controlled type 2 diabetic patients" @default.
- W2040320667 cites W1496638723 @default.
- W2040320667 cites W1590018298 @default.
- W2040320667 cites W1626249149 @default.
- W2040320667 cites W165957499 @default.
- W2040320667 cites W1906163725 @default.
- W2040320667 cites W1967888826 @default.
- W2040320667 cites W1972919038 @default.
- W2040320667 cites W1976596953 @default.
- W2040320667 cites W1984637736 @default.
- W2040320667 cites W2000724007 @default.
- W2040320667 cites W2002191861 @default.
- W2040320667 cites W2002565780 @default.
- W2040320667 cites W2016746758 @default.
- W2040320667 cites W2019441941 @default.
- W2040320667 cites W2029659869 @default.
- W2040320667 cites W2030352838 @default.
- W2040320667 cites W2032339969 @default.
- W2040320667 cites W2035126752 @default.
- W2040320667 cites W2038766003 @default.
- W2040320667 cites W2040636804 @default.
- W2040320667 cites W2044845204 @default.
- W2040320667 cites W2047394602 @default.
- W2040320667 cites W2050032102 @default.
- W2040320667 cites W2057758005 @default.
- W2040320667 cites W2061587443 @default.
- W2040320667 cites W2084784103 @default.
- W2040320667 cites W2087350450 @default.
- W2040320667 cites W2091360147 @default.
- W2040320667 cites W2095937988 @default.
- W2040320667 cites W2114299222 @default.
- W2040320667 cites W2138809584 @default.
- W2040320667 cites W2138928713 @default.
- W2040320667 cites W2157265784 @default.
- W2040320667 cites W2164162150 @default.
- W2040320667 cites W2164228805 @default.
- W2040320667 cites W2172253460 @default.
- W2040320667 cites W2207517510 @default.
- W2040320667 cites W2272753626 @default.
- W2040320667 cites W2313644270 @default.
- W2040320667 cites W2320229168 @default.
- W2040320667 cites W2410467940 @default.
- W2040320667 cites W4240633495 @default.
- W2040320667 cites W4246341680 @default.
- W2040320667 doi "https://doi.org/10.1016/s1262-3636(07)70289-6" @default.
- W2040320667 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16977262" @default.
- W2040320667 hasPublicationYear "2006" @default.
- W2040320667 type Work @default.
- W2040320667 sameAs 2040320667 @default.
- W2040320667 citedByCount "15" @default.
- W2040320667 countsByYear W20403206672014 @default.
- W2040320667 countsByYear W20403206672015 @default.
- W2040320667 countsByYear W20403206672019 @default.
- W2040320667 countsByYear W20403206672020 @default.
- W2040320667 countsByYear W20403206672021 @default.
- W2040320667 countsByYear W20403206672022 @default.
- W2040320667 crossrefType "journal-article" @default.
- W2040320667 hasAuthorship W2040320667A5005046202 @default.
- W2040320667 hasAuthorship W2040320667A5007052598 @default.
- W2040320667 hasAuthorship W2040320667A5007500703 @default.
- W2040320667 hasAuthorship W2040320667A5008628863 @default.
- W2040320667 hasAuthorship W2040320667A5012710468 @default.
- W2040320667 hasAuthorship W2040320667A5013875458 @default.
- W2040320667 hasAuthorship W2040320667A5036267969 @default.
- W2040320667 hasAuthorship W2040320667A5058869854 @default.
- W2040320667 hasAuthorship W2040320667A5059338767 @default.
- W2040320667 hasAuthorship W2040320667A5082690870 @default.
- W2040320667 hasAuthorship W2040320667A5091649746 @default.
- W2040320667 hasConcept C126322002 @default.
- W2040320667 hasConcept C134018914 @default.
- W2040320667 hasConcept C16224149 @default.
- W2040320667 hasConcept C185946421 @default.
- W2040320667 hasConcept C203014093 @default.
- W2040320667 hasConcept C2777180221 @default.
- W2040320667 hasConcept C2777448766 @default.
- W2040320667 hasConcept C2780221984 @default.
- W2040320667 hasConcept C555293320 @default.
- W2040320667 hasConcept C71924100 @default.
- W2040320667 hasConcept C90924648 @default.
- W2040320667 hasConceptScore W2040320667C126322002 @default.
- W2040320667 hasConceptScore W2040320667C134018914 @default.
- W2040320667 hasConceptScore W2040320667C16224149 @default.
- W2040320667 hasConceptScore W2040320667C185946421 @default.